Treatment疗程
Semaglutide
Semaglutide at Rejuuv Medi Spa, physician-led care in Markham, North York and Yorkville.
- Concern对应问题
- Body & Weight
- Category疗程分类
- Body & Health
- Care医疗团队
- Physician-led医生主导
- Clinics诊所
- Markham · North York · Yorkville万锦 · 北约克 · Yorkville
Benefits of Semaglutide
Semaglutide is prescribed for managing weight in patients with a body mass index (BMI) of 30 or higher. (27 or higher with accompanying weight-related disease) and to improve blood sugar control in adults with type 2 diabetes. Semaglutide works by increasing the level of the GLP-1 hormone, which helps the pancreas to produce more insulin. Semaglutide also helps to reduce the amount of sugar produced by the liver and delays the emptying of the stomach. Clinical studies have shown that semaglutide can help to lower HbA1c levels, body weight, and fasting blood sugar levels. [7] It may also help to reduce the risk of heart disease and complications such as eye and kidney problems.
Semaglutide for weight management
In clinical trials, participants lost 35 to 52 pounds through treatment with semaglutide, diet, and exercise. [8] More than 50% of trial participants lost 15% of their body weight, with around 40% of participants showing an overall loss of 20%.
In detail详细说明
Candidates for Semaglutide
The ideal candidate for semaglutide therapy is someone who:
- Has type 2 diabetes that is not well-controlled with other medications.
- Is willing to take a once-weekly injection (or daily oral tablet).
- Has a BMI of 30 or greater.
- Has a BMI of 27 or greater as well as a disease related to weight.
Semaglutide is not recommended for use in children, pregnant women or those who are planning to become pregnant. You should also not use semaglutide if you have a history of pancreatitis or diabetic ketoacidosis. Before starting semaglutide, advise Dr. Shawn Seit, M.D. about all other medications you are taking and any medical conditions you have. It is important that you discuss your medical history in detail with Dr. Shawn Seit, M.D. as Semaglutide can interact with other drugs and may not be safe for everyone.
Personal consultation
During your consultation Dr. Shawn Seit, M.D. will discuss your concerns about your health and how semaglutide therapy can help. Dr. Shawn Seit, M.D. will conduct a comprehensive examination and arrange any necessary blood tests and complete tests required to establish if you have prediabetes or diabetes. Additionally at your consultation you are welcome to discuss any additional health concerns. We offer a range of hormone treatments to optimize patient health.
Call today to set up your initial consultation to find out how Rejuuv Medi Spa can increase your vitality and treat your type 2 diabetes. We are here to help you manage your type 2 diabetes, lose weight, and feel better. Our staff is available to answer any of your questions contact us at (905) 695-6956 to schedule an appointment.
Common questions常见问题
Semaglutide is a GLP-1 receptor agonist that helps regulate appetite, increase feelings of fullness, and reduce food intake. For weight management, it is used alongside nutrition, physical activity, and ongoing medical care.
There is no single number that applies to everyone. Clinical trials found that participants taking semaglutide 2.4 mg alongside lifestyle changes lost an average of 14.9% of their starting body weight over 68 weeks. Individual results vary depending on factors such as your response to treatment, dose, lifestyle, starting weight, overall health, and duration of treatment.
The most common side effects are gastrointestinal and can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, bloating, and indigestion. These symptoms are often more noticeable when treatment begins or the dose increases and may improve as your body adjusts.
Mild gastrointestinal side effects can occur, especially when starting treatment or increasing the dose. Eating smaller meals, stopping when you feel full, staying well hydrated, and avoiding foods that trigger symptoms may help. Your physician will also assess your symptoms and determine whether your treatment plan or dose progression should be adjusted.
Semaglutide has been studied extensively, but like any prescription medication it has benefits, side effects, contraindications and potential risks. Whether it is appropriate for you depends on your individual health profile. This is why Rejuuv’s program begins with medical assessment and includes ongoing physician monitoring.
Semaglutide is available in injection and tablet form. The injection is administered once weekly, while the tablet is taken once daily. [4] The injection is administered under the skin of the upper arm, stomach, or thigh. To ensure proper rotation of injection sites, it is important to keep track of where you administer the semaglutide shot and use a different body area each time. In addition Dr. Shawn Seit, M.D. directs his patients to follow these guidelines while taking semaglutide [6] :
- Don’t mix semaglutide with insulin in the same syringe
The main mechanism of semaglutide is to aid in the reduction of blood sugar levels, while also decreasing the necessary insulin production in the body. Although semaglutide is generally well-tolerated, nausea and vomiting are the most reported side effects. These side effects are usually mild and settle with continued treatment. If you are considering using semaglutide, talk to one of our helpful staff members so we can set up an appointment with Dr. Shawn Seit, M.D. to discuss the benefits and risks. Call (905) 695-6956 or fill out this form, and we will be in touch shortly.
Currently, semaglutide is not covered by insurance in Canada. This may change in the future as semaglutide continues to be studied for its potential health benefits.
- Sinnott M, Kinsley BT, Jackson AD, et al. Fasting Plasma Glucose as Initial Screening for Diabetes and Prediabetes in Irish Adults: The Diabetes Mellitus and Vascular Health Initiative (DMVhi). Wang G, ed. PLOS ONE. 2015;10(4):e0122704. doi:10.1371/journal.pone.0122704
- Commissioner O of the. FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. FDA. Published June 4, 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
- Lages M, Barros R, Moreira P, Guarino MP. Metabolic Effects of an Oral Glucose Tolerance Test Compared to the Mixed Meal Tolerance Tests: A Narrative Review. Nutrients. 2022;14(10):2032. doi:10.3390/nu14102032
- Goldenberg RM, Steen O. Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes. Canadian Journal of Diabetes. 2019;43(2):136-145. doi:10.1016/j.jcjd.2018.05.008
- Phillips A, Clements JN. Clinical review of subcutaneous semaglutide for obesity. Journal of Clinical Pharmacy and Therapeutics. Published online December 28, 2021. doi:10.1111/jcpt.13574
- Semaglutide (Subcutaneous Route) Proper Use – Mayo Clinic. www.mayoclinic.org. https://www.mayoclinic.org/drugs-supplements/semaglutide-subcutaneous-route/proper-use/drg-20406730
- Miles KE, Kerr JL. Semaglutide for the Treatment of Type 2 Diabetes Mellitus. Journal of Pharmacy Technology. 2018;34(6):281-289. doi:10.1177/8755122518790925
- CNN SL and VL. Overweight people lost 35 to 52 pounds on newly approved diabetes drug, study says. CNN. Published 2022. https://www.cnn.com/2022/06/06/health/weight-loss-drug-diabetes-wellness/index.html
- Savings card offers. www.novocare.com. Accessed August 15, 2022. https://www.novocare.com/diabetes-overview/savings-offers.html
No questions match your search.没有匹配的问题。
Before and after疗程前后对比

Results are not guaranteed and may vary between patients. Photos show actual patients treated at Rejuuv Medi Spa.疗程效果因人而异,不作保证。照片为本院真实客人案例。
More about Semaglutide
Losing weight isn’t always as simple as eating less and exercising more. Appetite, hormones, metabolism, genetics, medications, sleep, and other health factors can all influence how your body manages weight.
Semaglutide is a prescription medication that can support long-term weight management by helping regulate appetite and increasing feelings of fullness. At Rejuuv Medi Spa, semaglutide is offered as part of a physician-monitored weight management program, with your treatment personalized according to your health, goals, response, and tolerance.
Rather than simply prescribing medication, our goal is to help you approach weight management safely, realistically, and with ongoing medical support.
What Is Semaglutide?
Semaglutide belongs to a class of medications called GLP-1 receptor agonists[1]. It works similarly to GLP-1, a naturally occurring hormone released by the body after eating. One of GLP-1’s roles is communicating with areas of the brain involved in appetite and fullness. Semaglutide can help you feel fuller and less hungry, making it easier to reduce food intake and maintain healthier eating habits over time. Semaglutide is also used in certain formulations to help manage blood sugar in adults with type 2 diabetes. At Rejuuv, our program is focused on its role in medical weight management for appropriate patients. Health Canada has authorized semaglutide products[2] for both type 2 diabetes and chronic weight management, depending on the specific product and indication.
How Does Semaglutide Help With Weight Management?
Reduced Appetite
Semaglutide affects appetite-regulating pathways in the brain[3], helping reduce hunger and making smaller portions feel more satisfying.
Increased Fullness
You may feel satisfied sooner and stay full for longer after eating, which can make it easier to manage portions and overall calorie intake.
Fewer Cravings
For some people, having less persistent hunger can make it easier to make intentional food choices instead of constantly thinking about the next meal.
Sustainable Weight Management
Semaglutide is designed to support long-term weight management when used together with healthy lifestyle habits and appropriate medical supervision.
Benefits of Semaglutide
For appropriate candidates, semaglutide may help with:
- Meaningful, gradual weight loss
- Reduced hunger and appetite
- Feeling full with smaller portions
- Improved ability to maintain a calorie-controlled diet
- Improvements in certain weight-related health markers
Results vary from person to person. Studies show adults with overweight or obesity who received once-weekly semaglutide 2.4 mg together with lifestyle intervention lost an average of [4]14.9% of their starting body weight over 68 weeks, compared with 2.4% among participants receiving placebo and lifestyle intervention. Individual results can be significantly higher or lower.
What Can I Expect?
Semaglutide used for weight management is typically administered as a once-weekly injection under the skin. Everyone responds differently. Some people notice changes in appetite relatively early, while meaningful changes in body weight generally develop gradually over several months.[5] Your physician will monitor how you respond and adjust your treatment when appropriate. The goal is progress instead of rapid weight loss at any cost.
Side Effects of Semaglutide
Like any prescription medication, semaglutide can cause side effects. Gastrointestinal symptoms are the most common, particularly while your body is adjusting to treatment.
Common Side Effects may include:[6]
- Bloating or indigestion
- Headache
- Fatigue
Your physician will review the potential benefits and risks with you before treatment and advise you on symptoms that require medical attention. This is one reason we believe medical supervision matters.
The Rejuuv Approach
1. Physician Consultation
Your journey begins with a medical consultation. Your physician will review your medical history, current medications, previous weight-management efforts, goals, and any factors that may affect whether semaglutide is appropriate for you.
2. Prescription & Pharmacy Dispensing
If semaglutide is appropriate for you, your physician will provide a prescription that can be sent to a licensed Canadian pharmacy for dispensing.
3. Personalized Treatment Plan
Treatment typically begins at a lower dose and is gradually adjusted over time. Our medical provider will determine your dosing plan based on how your body responds and how well you tolerate the medication.
4. Ongoing Medical Monitoring
Your progress is monitored throughout the program. This may include reviewing:
- Weight-management progress
- Appetite and eating patterns
- Treatment response
- Side effects and tolerability
- Overall health and wellbeing
Your physician can adjust your treatment when appropriate and address any concerns that arise along the way.
5. Long-Term Weight Management
We want to help you develop a realistic and sustainable approach to weight management, with medical support, healthier habits, and a plan designed around your individual needs.
FRequently asked questions
Is semaglutide the same as Ozempic?
Semaglutide is the active ingredient, while Ozempic and Wegovy are brand names for semaglutide products with different approved uses and dosing regimens. In Canada, Wegovy is specifically authorized for chronic weight management in eligible patients.
Your physician will determine which treatment, if any, is appropriate for you.
How much weight can I lose?
In a clinical trial[7], participants receiving semaglutide 2.4 mg plus lifestyle intervention lost an average of 14.9% of their starting body weight over 68 weeks. Your results can vary depending on your response to treatment, dose, lifestyle, starting weight, health and how long you remain on treatment.
Do I still need to watch my diet and exercise?
Yes. Semaglutide is intended to complement, not replace healthy nutrition and physical activity.
Because appetite may be reduced, the quality of what you eat becomes especially important. Your Rejuuv team can discuss habits that support your overall treatment plan.
What happens if I experience side effects?
Your physician can assess your symptoms and determine whether your treatment plan or dose progression should be adjusted.
References
- GLP-1 Agonists. Cleveland Clinic. https://my.clevelandclinic.org/. Last updated July 03, 2023. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
- Regulatory Decision Summary for Wegovy. Drug and Health Product Portal. https://dhpp.hpfb-dgpsa.ca/. https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00896
- Sharath Kommu; Philip Whitfield. Semaglutide. Last Update: February 11, 2024. https://www.ncbi.nlm.nih.gov/books/NBK603723/
- John P.H. Wilding, D.M., Rachel L. Batterham, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. Published February 10, 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- Mo Ojeniran, Betty Dube, Allison Paige, Joey Ton and Adrienne J. Lindblad. Semaglutide for weight loss. November 1, 2021. https://www.cfp.ca/content/67/11/842
- Kristianne Hannemann, PharmD. Wegovy Side Effects. July 16, 2026. https://www.drugs.com/sfx/wegovy-side-effects.html
- Rachel S Chang, Jiun-Ruey Hu, Hsin-Chieh Yeh. Once-Weekly Semaglutide with Lifestyle Intervention Results in Clinically Significant Weight Loss. 2022 Mar 1;37(7):1824–1826. https://pmc.ncbi.nlm.nih.gov/articles/PMC9130404/
More on this treatment更多相关页面